Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Rubius Therapeutics, Inc. (RUBY)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
24 Feb 2023
Appelhans Dannielle
CEO and President, Officer
Rubius Therapeutics, Inc.
(RUBY)
0
-100%
10,385
$0.13
$1,323.05
SELL
1 Feb 2023
CAGNONI PABLO J
Director
Rubius Therapeutics, Inc.
(RUBY)
66,082
-11%
8,448
$0.25
$2,112.00
SELL
31 Jan 2023
Appelhans Dannielle
CEO and President, Officer
Rubius Therapeutics, Inc.
(RUBY)
10,385
-27%
3,878
$0.25
$969.50
SELL
29 Jan 2023
CAGNONI PABLO J
Director
Rubius Therapeutics, Inc.
(RUBY)
74,530
-8%
7,240
$0.24
$1,744.84
SELL
29 Jan 2023
Turka Laurence A.
Chief Scientific Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
18,391
-12%
2,593
$0.24
$622.32
SELL
9 Aug 2022
Appelhans Dannielle
Chief Operating Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
6,763
-45%
5,737
$0.80
$4,589.60
BUY
21 Apr 2022
Epstein David R
Director
Rubius Therapeutics, Inc.
(RUBY)
4,720,012
+0%
30,000
$1.44
$43,329.00
SELL
29 Jan 2022
CAGNONI PABLO J
CEO and President, Director, Officer
Rubius Therapeutics, Inc.
(RUBY)
35,520
-15%
6,730
$6.57
$44,236.29
SELL
29 Jan 2022
Keson-Brookes Maiken
CLO & Corp. Secretary, Officer
Rubius Therapeutics, Inc.
(RUBY)
5,343
-33%
2,732
$6.57
$17,957.44
SELL
29 Jan 2022
Turka Laurence A.
Chief Scientific Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
4,921
-33%
2,517
$6.57
$16,544.24
BUY
19 Mar 2021
Flagship Ventures Fund IV General Partner LLC
10% Owner
Rubius Therapeutics, Inc.
(RUBY)
15,393,593
+1%
210,000
$29.00
$6,090,000.00
SELL
15 Mar 2021
Keson-Brookes Maiken
CLO & Corp. Secretary, Officer
Rubius Therapeutics, Inc.
(RUBY)
0
-100%
25,000
$20.24
$505,965.00
SELL
11 Feb 2021
Epstein David R
Director
Rubius Therapeutics, Inc.
(RUBY)
4,690,012
-0%
26,704
$14.93
$398,559.88
SELL
8 Feb 2021
Epstein David R
Director
Rubius Therapeutics, Inc.
(RUBY)
4,716,716
-2%
98,737
$14.88
$1,468,788.40
BUY
22 Apr 2020
Coughlin Christina M.
Chief Medical Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
19,000
+100%
19,000
$5.52
$104,813.50
BUY
14 Apr 2020
CAGNONI PABLO J
CEO and President, Director, Officer
Rubius Therapeutics, Inc.
(RUBY)
21,000
+100%
21,000
$4.70
$98,693.70
BUY
17 Mar 2020
Epstein David R
Director
Rubius Therapeutics, Inc.
(RUBY)
4,815,453
+0%
5,000
$3.76
$18,800.00
BUY
13 Mar 2020
Epstein David R
Director
Rubius Therapeutics, Inc.
(RUBY)
4,805,453
+0%
10,000
$3.91
$39,100.00
SELL
16 Dec 2019
CARPENTER CHRISTOPHER L.
Chief Medical Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
34,843
-57%
48,000
$13.48
$646,900.80
SELL
14 Oct 2019
LANGER ROBERT
Director
Rubius Therapeutics, Inc.
(RUBY)
0
-100%
7,500
$8.52
$63,874.50
SELL
16 Sep 2019
CARPENTER CHRISTOPHER L.
Chief Medical Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
34,843
-57%
48,000
$10.11
$485,206.30
SELL
15 Jul 2019
LANGER ROBERT
Director
Rubius Therapeutics, Inc.
(RUBY)
0
-100%
7,500
$14.94
$112,048.50
SELL
20 Jun 2019
CARPENTER CHRISTOPHER L.
Chief Medical Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
34,843
-0%
243
$13.93
$3,385.96
SELL
17 Jun 2019
CARPENTER CHRISTOPHER L.
Chief Medical Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
34,843
-57%
47,757
$14.02
$669,693.90
SELL
15 Apr 2019
LANGER ROBERT
Director
Rubius Therapeutics, Inc.
(RUBY)
0
-100%
7,500
$17.57
$131,799.00
SELL
8 Apr 2019
NISSEN TORBEN STRAIGHT
President, Officer
Rubius Therapeutics, Inc.
(RUBY)
1,845,304
-0%
2,100
$20.00
$42,000.00
SELL
3 Apr 2019
NISSEN TORBEN STRAIGHT
President, Officer
Rubius Therapeutics, Inc.
(RUBY)
1,847,404
-0%
12,596
$20.00
$251,920.00
SELL
15 Mar 2019
CARPENTER CHRISTOPHER L.
Chief Medical Officer, Officer
Rubius Therapeutics, Inc.
(RUBY)
34,843
-57%
48,000
$15.84
$760,113.60
SELL
14 Jan 2019
LANGER ROBERT
Director
Rubius Therapeutics, Inc.
(RUBY)
0
-100%
7,500
$14.59
$109,443.75
BUY
20 Jul 2018
Symonds Jonathan
Director
Rubius Therapeutics, Inc.
(RUBY)
25,000
+100%
25,000
$23.00
$575,000.00
BUY
20 Jul 2018
Pomerantz Roger
Director
Rubius Therapeutics, Inc.
(RUBY)
100
+100%
100
$23.00
$2,300.00
BUY
20 Jul 2018
Sohn Catherine A.
Director
Rubius Therapeutics, Inc.
(RUBY)
2,500
+100%
2,500
$23.00
$57,500.00
BUY
20 Jul 2018
Cuss Francis M
Director
Rubius Therapeutics, Inc.
(RUBY)
10,000
+100%
10,000
$23.00
$230,000.00
Home